Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric Reyner
Eric Reyner
Genentech
Medicine
Internal medicine
Oncology
Pharmacokinetics
HER2 negative
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer
2019
Breast Cancer Research and Treatment
Vandana G. Abramson
Mafalda Oliveira
Andrés Cervantes
Hans Wildiers
Manish R. Patel
Todd Michael Bauer
Philippe L. Bedard
Carlos Becerra
Stephen Lane Richey
Michael C. Wei
Eric Reyner
John Bond
Na Cui
Timothy R. Wilson
Heather M. Moore
Cristina Saura
Ian E. Krop
Show All
Source
Cite
Save
Citations (1)
Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer Therapy.
2019
Clinical and Translational Science
Eric Reyner
Bert L. Lum
Jing Jing
Matts Kågedal
Joseph A. Ware
Leslie J. Dickmann
Show All
Source
Cite
Save
Citations (2)
1